[ad_1]
Acumen Research and Consulting, a global supplier of market research, in a recently published report entitled " Medical Imaging Reagent Market (Clbad: Contrast Reagents, Optical Reagents , Nuclear reagents, Technology: Nanoparticles, Fluorescent dyes and probes, radiopharmaceuticals, fluorescent proteins, quantum dots, application: diagnostics, drug discovery and development, research and development) – Analysis of the global industry, size of the market, Opportunities and Forecasts 2023 " estimates that the global market for medical imaging reagents is expected to reach market value of about $ 18.5 billion by 2023 and is expected to grow to a CAGR of about 8.0% in terms of revenue over the period 2017 – 2023. Some of the key factors supporting market growth include anoint and the demand for functional imaging diagnostics. In addition, key players are trying to innovate technology such as hybrid imaging modalities to improve the imaging system's productivity, which should increase the growth of the reagents market. d & # 39; imaging. In addition, the increase in the number of cancer patients with increased demand for superior diagnostic imaging technologies is driving the growth of this market. However, stringent regulations, the shortage of these reagents and reluctance to adopt and accept nuclear reagents can hinder market growth.
Download examples of pages @ https://www.acumenresearchandconsulting.com/request-sample/537 [19659003] Increasing Prevalence of Chronic Disease
The increasing incidence of chronic diseases such as heart disease, Stroke, Type II Diabetes and Cancer is driving the market for medical imaging reagents. For example, cardiovascular disease is one of the leading causes of death in the world. According to the report "Heart Diseases and Stroke 2015" published by the American Heart Association, 17.3 million deaths occur each year due to cardiovascular disease, and this number is expected to reach 23.6 million. here 2030. Similarly, stroke is one of the leading causes of death, overall. It accounted for 11.13% of the total number of deaths worldwide in 2015. Thus, an increase in the number of these chronic diseases could increase the demand for diagnostic and therapeutic imaging modalities, thereby driving the growth of market in the coming years. In addition, older patients are most at risk for chronic diseases; thus, the rapid increase in the geriatric population would further drive the demand for medical imaging reagents.
Browse full report with table of contents and list of tables and figures -https: //www.acumenresearchandconsulting.com/medical-imaging-reagents-market
Insights on Market Segments
The global market for reagents for medical imaging is segmented by clbad, technology, application and region. Based on the clbad, it is divided into contrast reagents, optical reagents and nuclear reagents. Depending on the technology, the market is categorized as fluorescent dyes and probes, nanoparticles, radiopharmaceuticals, quantum dots and fluorescent proteins. Based on the application, the market is clbadified in diagnostics, discovery and drug development, and R & D. Based on the region it is badyzed in North America, Europe, Asia-Pacific and LAMEA
. the demand for contrast reagents
Different types of contrast reagents available on the market include contrast-based barium, gadolinium-based and iodinated contrast reagents, all of which are used in medical imaging equipment. Contrast reagents are administered from different routes such as injectable, rectal, urethral and oral. In 2016, based on the clbad, the contrast reagent segment held the largest share of the global market for medical imaging reagents. Contrast reagents are applicable in different procedures such as ultrasound, computed tomography and magnetic resonance imaging (MRI).
The global market for medical imaging reagents is strongly consolidated due to the presence of a few international and regional players. The key players considered in this report include Lantheus Medical Imaging, Inc., Covalon Technologies Ltd., GE Healthcare, Bayer Healthcare AG, Siemens Healthcare, Merck, Bracco Imaging SpA, Shimadzu Corporation, Philips Healthcare and Thermo Fisher Scientific, Inc.
Make a request for information to purchase this report @ https://www.acumenresearchandconsulting.com/inquiry-before-buying/537
Table of Contents
Chapter 1. Scope and Methodology of Research
1.1 Description of Report
1.2 Main Benefits
1.3 Main Market Segments
1.4 Research Methodology
1.4.1 Secondary Research
1.4 .2 Primary Research [19659011] 1.4.3 Analyst Tools and Models
Chapter 2. Summary
2.1 CxO Perspective
Chapter 3. Market Overview
3.1 Market Definition and Scope [19659011] 3. 2 Main Findings
3.2.1 Best Investment Strategies
3.2.2 Most Successful Winning Strategies [1 9659011] 3.3 Player Position Analysis
3.4 Analysis of Porter's Five Forces
3.4 .1 Bargaining Power of Buyers
3.4.2 Trading Power of Suppliers
3.4.3 Threat of New Entrants
3.4.4 Threat of Substitutes
3.4.5 Level of Competition
3.5 Government Regulations
3.5.1 United States FDA
3.6 Repayment Scenario
3.7 Market Dynamics
3.7.1 Drivers
3.7. 1.1 Increasing Prevalence of Chronic Diseases
3.7.1.2 Increased Response to Early Diagnosis of Disease
3.7.1.3 Accelerated Demand for Diagnostic Imaging Procedures
3.7.2 Restrictions
3.7 .2.1 Low Availability of Imaging Supplies Reagents
3.7.2.2 Costly Medical Imaging Procedures
3.7.2.3 Reluctance in the Adoption of Nuclear Reagents
3.7.3 Opportunities [19659011] 3.7.3.1 Technological Progress
3.7.3.2 Untapped Markets in Emerging Economies [19659003] Chapter 4. Medical Imaging Agents Market Analysis, by Clbad
4.1 Overview
4.1.1 Pharmaceutical Reagents Global Medical Imaging Market Size and Forecasts, by Clbad, 2016 – 2023 (in millions of dollars)
4.2 Contrast Reagents
4.2.1 Key Market Trends
4.2.2 Key Drivers of Growth and Prospects
4.2.3 Contrast reagents for medical imaging Market Size and Forecasts, by Region, 2016 – 2023 (in millions of dollars)
4.3 Optical Reagents
4.3.1 Legend Market Trends
4.3.2 Key Drivers of Growth and Opportunities
4.3.3 Optical Medical Imaging Reagents Size and Market Forecast, by Region, 2016 – 2023 (in millions of dollars)
4.4 Nuclear Reagents
4.4.1 Main Market Trends
4.4.2 Key Drivers of Growth and Outlook
4.4.3 Nuclear Medical Imaging Reagents Size and Market Forecast, by Region, 2016 – 2023 (in Millions of Dollars)
Chapter 5. Medical Imaging Reagents Market Analysis, By Technology
5.1 Overview
5.1.1 Global Medical Imaging Reagents Market Size and Forecasts, according to technology, 2016 – 2023 (in millions of dollars s)
5.2 Nanoparticles
5.2.1 Market for medical imaging reagents for nanoparticles, size and market forecasts, by region, 2016 – 2023 (in millions of dollars)
5.3 Fluorescent Dyes and Probes
5.3.1 Medical Imaging Reagent Market for Dyes and Fluorescent Probes, Size and Market Forecast, by Region, 2016 – 2023 (in millions of dollars)
5.4 Radiopharmaceuticals [19659011] 5.4.1 Medical imaging reagents market Radiopharmaceuticals, market size and forecasts, by region, 2016 – 2023 (millions of dollars)
5.5 Fluorescent Proteins
5.5.1 Pharmaceutical reagents market 39 Medical Imaging for Fluorescent Proteins, Size and Market Forecast, by Region, 2016 – 2023 ($ Million)
5.6 Quantum Dots
5.6.1 Medical Imaging Reagent Market for Quantum Dots , the size of my and forecasts, by region, 2016 – 2023 (in millions of $)
Chapter 6. Medical Imaging Reagents Market Analysis Application
6.1 Overview
6.1.1 Global Med Size and Forecasts market for medical imaging reagents, as required, 2016 – 2023 (in millions of dollars)
6.2 Diagnostics
6.2.1 Size and market forecasts of medical imaging reagents for applications Diagnostics, by Region, 2016 – 2023 (in millions of $)
6.3 Drug Research and Development
6.3.1 Size and Forecast of the Medical Imaging Reagent Market for the Research and Development Application Drug Development, by Region, 2016 – 2023 (millions of dollars)
6.4 Research and Development (R & D) [19659011] 6.4.1 Medical Imaging Reagents Market Size and Forecasts for. application of R & D, by region, 2016 – 2023 (in millions of dollars) [19659003] Chapter 7. Market Analysis of Medical Imaging Reagents, by Region
7.1 Overview
7.1.1 Size and Forecast of Global Market for Medical Imaging Reagents, by Region, 2016 – 2023 (in millions of dollars)
7.2 North America
7.2.1 Main Market Trends
7.2.2 Key Drivers of Growth and Opportunities
7.2. 3 Size and Forecast of the Medical Imaging Reagent Market in North America, by Clbad, 2016 – 2023 (in millions of dollars)
7.2.4 North America Size and Market Forecast of Medical Reagents medical imaging, by technology, 2016 – 2023 (in millions of dollars)
7.2.5 Medical imaging reagents in North America By application, 2016 – 2023 (millions of dollars)
7.2 .6 North America Medical Imaging Reagents Size and Market Forecast, by Country, 2016 – 2023 (in millions of dollars)
7.2.6.1 United States
7.2.6.1. 1 Size and Forecast of the US Market for Medical Imaging Reagents, 2016 – 2023 (in millions of dollars)
7.2.6.2 Canada
7.2.6.2.1 Size and Forecast of the Market for Medical Imaging Reagents Medical Imaging in Canada, 2016 – 2023 (in millions of dollars) [196590117263Mexico
7.2.6.3.1 Mexico Size and Forecast of Medical Imaging Reagents Market, 2016 – 2023 (in millions of dollars) [19659011] 7.3 Europe
7.3.1 Main market trends
7.3.2 Legend Growth factors and opportunities
7.3.3 Medical imaging reagents in Europe Market size and forecasts, by clbad, 2016 – 2023 (in millions of dollars)
7.3.4 Europe Medica l Size and market forecasts of imaging reagents, by technology, 2016 – 2023 (millions of dollars)
7.3.5 Medical Imaging Reagents in Europe Size and Market Forecast, According to Demand, 2016 – 202 3 (in millions of dollars)
Size and Forecasting of the Medical Imaging Reagent Market, by Country, 2016 – 2023 (in millions of dollars)
7.3.6.1 Germany
7.3.6.1. 1 Size and Market Forecast of Medical Imaging Reagents in Germany, 2016 – 2023 (in millions of dollars) [19659011] 7.3.6.2 France
7.3.6.2.1 France Size and market forecasts for reagents Medical Imaging, 2016 – 2023 (in millions of dollars)
7.3.6.3 United Kingdom
7.3.6.3.1 UK Market for Medical Imaging Reagents Size and Forecast, 2016 – 2023 (in millions of dollars)
7.3.6.4 Italy
7.3.6.4.1 Italy Size and market forecasts of medical imaging reagents, 2016 – 2023 (millions of dollars)
7.3.6.5 Spain [19659011] 7.3.6.5.1 Spain Medical Imaging Reagents Market Size and Forecasts, 2016 – 2023 (in millions of dollars)
7.3.6.6 Remainder of & # 39; Europe
7.3.6.6.1 Rest of Europe Medic Imaging Protein Market Size and Forecast, 2016 – 2023 (in millions of dollars)
7.4 Asia-Pacific
7.4.1 Key Market Trends
7.4.2 Key Drivers of Growth and Prospects
7.4.3 Asia- Pacific Medical Imaging Reagents Market, by Clbad, 2016 – 2023 (in $ millions)
7.4.4 Medical imaging reagents in Asia-Pacific Size and market forecasts, by technology, 2016 – 2023 (in millions of dollars)
7.4.5 Asia Size and market forecasts medical imaging reagents, by application, 2016 – 2023 (in millions of dollars)
7.4.6 Size and Forecast of Medical Imaging Reagents Market in Asia-Pacific, by Country, 2016 – 2023 (in millions of dollars)
7.4.6.1 Japan
7.4.6.1.1 Size and forecast of the market for medical imaging reagents in Japan, 2016 – 2023 (in millions of dollars)
7.4.6.2 China
7.4.6.2.1 China Market Size of Medical Imaging Reagents And Forecasts, 2016 – 2023 (in millions of dollars) [19659011] 7.4.6.3 Australia
7.4.6.3.1 Australia Size and Forecast of the Medical Imaging Reagent Market, 2016 – 202 3 (in millions of dollars)
7.4.6.4 India
7.4. 6.4.1 Size and Forecast of the Medical Imaging Reagent Market in India, 2016 – 2023 (in millions of dollars)
7.4.6.5 South Korea
7.4.6.5 .1 Size and Market Forecast medical imaging reagents in South Korea, 2016 – 2023 (in millions of dollars)
7.4.6.6 Taiwan
7.4.6.6.1 Size and market forecasts of medical imaging reagents of Taiwan, 2016 – 2023 (in millions of dollars)
7.4.6.7 Remainder of the Asia-Pacific
7.4.6.7.1 Remainder of the size and forecasts of the reacti Medical imaging in Asia-Pacific, 2016 – 2023 (in millions of dollars)
7.5 LAMEA
7.5.1 Main market trends
7.5.2 Main factors and opportunities for growth
] 7.5.3 LAMEA Medical Imaging Reagents Size and Market Forecast, by Clbad, 2016 – 2023 (in millions of dollars)
7.5.4 LAMEA Medical Imaging Reagent Market Size and Forecast, according to technology, 2016 – 2023 (in millions of dollars)
7.5.5 Size and Market Forecast of LAMEA Medical Imaging Reagents, according to demand, 2016 – 2023 (in millions of dollars)
7. 5.6 Size and Forecast of the LAMEA Medical Imaging Reagent Market, by Country, 2016 – 2023 (in millions of dollars)
7.5.6.1 Brazil
7.5.6.1.1 Size and Forecast of the Reagent Market Medical imaging in Brazil, 2016 – 2023 (in millions of dollars
7.5.6.2 South Africa
7.5.6.2.1 South Africa Medical Imaging Reagents Size and Market Forecast, 2016 – 2023 (in millions of dollars)
7.5.6.3 Saudi Arabia
7.5.6.3.1 7.5.6.4 Remainder of LAMEA
7.5.6.4.1 Remainder of the market for medical imaging reagents LAMEA Size and Forecast, 2016 – 2023 ($ Million)
Chapter 8. Company Profiles
8.1 Bracco Spa
8.1.1 Overview of the Company
8.1.2 Overview of the Company Business
8.1.3 Operating Segments
8.1.4 Product Portfolio
] 8.1.5 Business Performance
8.2 Lantheus Holdings, Inc.
8.2.1 Presentation of the Company
8.2.2 Overview of the Company
8.2.3 Operation of Segmen
8.2.4 Product Portfolio
8.2.5 Performance of the Company Company
8.3 GE Healthcare
8.3.1 Company Overview
8.3.2 Business Overview
8.3.3 Segments of Operations
8.3. 4 Product Portfolio
8.3.5 Commercial Performance
8.3.6 Major Movements and Strategic Developments
8.4 Siemens AG
8.4.1 Overview of the Company
8.4.2 Overview of the Company [19659011] 8.4 .3 Operating Areas
8.4.4 Commercial Performance
8.5 Bayer AG
8.5.1 Overview of the Company
8.5.2 Overview of the Business
8.5.3 Operating Segments
8.5.4 Product Portfolio
8.5.5 Business Performance
8.6 CMC Contrast AB
8.6.1 Aper u of the Company
8.6.2 Overview of the Business
8.6.3 Segments of Operations
8.6.4 Major Strategic Movements and Developments
8.7 Thermo Fisher Scientific, Inc.
8.7.1 Overview of the Company
8.7.2 Business Overview
8.7.3 Segments of Operations
8.7.4 8.7.5 Performance of the Company company
8.8 Merck & Co., Inc.
8.8.1 Company Overview
8.8.2 Business Overview
8.8.3 Operating Segments
8.8. 4 Business Performance
8.9 Shimadzu Corporation
8.9.1 Company Overview
8.9.2 Business Overview
8.9.3 Operating Segments
8.9. 4 Commercial Performance
8.10 Koninklijke Philips NV [19659011] 8.10.1 Business Overview
8.10.2 Business Overview
8.10.3 Operating Segments
8.10.4 Commercial Performance
The report is easily accessible and can be sent immediately after confirmation of payment.
Buy this premium search back at https://www.acumenresearchandconsulting.com/buy-now/0/537
Want to place an order or ask any questions, please n & # Feel free to contact [email protected]
About Us
Acumen Research and Consulting (ARC) is a global provider of business intelligence and consulting services for technology markets information, investment, telecommunications, manufacturing and consumer technologies. The CRA helps investor communities, IT professionals and business leaders make evidence-based decisions about technology purchases and develop growth strategies to compete in the market. With a team of more than 100 badysts and a collective experience of more than 200 years in the sector, Acumen Research and Consulting provides a combination of industry knowledge and global and national expertise.
Contact:
Frank Wilson
Director of Sales | Acumen Research and Consulting
E-mail: [email protected]
Ph – US +1 716-2400-831
Asia-Pacific +912065600384 ]
Web: https://www.acumenresearchandconsulting.com/
Blog: http://pharmainvestmentnews.com/
Blog: http://chemicalandmaterials.com/
Source link
